Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Operating expenses:
Research and development	$ 2,057,421	$ 1,610,822	$ 6,948,816	$ 3,510,118
General and administrative	1,302,401	274,512	2,792,424	1,054,479
Loss from operations	3,359,822	1,885,334	9,741,240	4,564,597
Other income (expense):
Interest income	2,993	136	4,819	174
Interest expense	(120,229)	0	(242,982)	0
Loss on disposal of asset	(967)	0	(967)	0
Total other income (expense), net	(118,203)	136	(239,130)	174
Net loss	$ (3,478,025)	$ (1,885,198)	$ (9,980,370)	$ (4,564,423)
Basic and diluted loss per share	$ (1.09)	$ (0.77)	$ (3.69)	$ (1.86)
Weighted average common shares outstanding - basic and diluted	3,199,796	2,450,000	2,702,678	2,450,000